Latest EUCR reports update at 2023-04-13: 20222021
Eucrates Biomedical Acquisition Corp. logo

Eucrates Biomedical Acquisition Corp. EUCR

$ 10.04 0.0%

Country

usaUSA

IPO year

2020

Industry

-

Stock Exchange

NASDAQ CAPITAL

CEO

-

Employees in the company

-

Shares

2.98 M

Market Cap[1]

$ 42.2 M

EBITDA (LTM)

$ -695 K

P/E (LTM)

-505.0

P/S (LTM)

-

EPS (LTM)

-0.02

References

  1. Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.